A pilot study of individualized maximum repeatable dose (iMRD), a new dose finding system, of weekly gemcitabine for patients with metastatic pancreas cancer
Journal
-
- Cancer Research Institute report
-
Cancer Research Institute report 2003-2005 93-, 2006-03-01
金沢大学がん研究所
- Tweet
Details 詳細情報について
-
- CRID
- 1050564285940095872
-
- NII Article ID
- 120000814040
-
- ISSN
- 03880192
-
- Web Site
- http://hdl.handle.net/2297/2635
-
- Text Lang
- en
-
- Article Type
- departmental bulletin paper
-
- Data Source
-
- IRDB
- CiNii Articles